tiprankstipranks
OSE Immunotherapeutics SA (DE:6OP)
FRANKFURT:6OP
Holding DE:6OP?
Track your performance easily

OSE Immunotherapeutics SA (6OP) Cash flow

1 Followers

OSE Immunotherapeutics SA Cash Flow

DE:6OP's free cash flow for Q2 2022 was €―. For the 2022 fiscal year, DE:6OP's free cash flow was decreased by €9.37M and operating cash flow was €―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
-€ -9.92M€ -19.55M€ 9.13M€ 1.08M€ -8.00M
Investing Cash Flow
-€ -827.00K€ -504.00K€ 2.38M€ -558.00K€ -299.00K
Financing Cash Flow
-€ 14.96M€ 23.58M€ 4.76M€ -592.00K€ 3.06M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-€ 33.58M€ 29.37M€ 25.84M€ 9.57M€ 9.65M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-€ 265.00K€ 18.63M€ 0.00€ 30.00K€ 35.00K
Issuance Of Debt
-€ 15.28M€ 6.96M€ 5.63M€ 0.00€ 3.56M
Repayment Of Debt
-€ -40.00K€ -325.00K€ -455.00K€ -485.00K€ -465.00K
Free Cash Flow
-€ -10.39M€ -19.76M€ 8.80M€ 484.00K€ -8.35M
Domestic Sales
------
Foreign Sales
------
Currency in EUR

OSE Immunotherapeutics SA Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis